Impaired Vagal Activity in Long-COVID-19 Patients

Domenico Acanfora1, Maria Nolano2,3, Chiara Acanfora1,4

  • 1Department of Internal Medicine, San Francesco Hospital, Viale Europa 21, 82037 Telese Terme, Italy.

Viruses
|May 28, 2022
PubMed

Insights

Long COVID-19 patients exhibit autonomic nervous system dysfunction, indicated by altered heart rate variability. This dysautonomia, linked to elevated D-dimer and NT-ProBNP, may explain persistent symptoms and requires monitoring.

Area of Science:

  • Cardiology
  • Neurology
  • Infectious Diseases

Background:

  • Long COVID-19, characterized by persistent symptoms post-acute infection, is associated with increased risks of multiorgan dysfunction, readmission, and mortality.
  • Biomarkers such as D-Dimer and NT-ProBNP, along with autonomic nervous system dysfunction, are frequently observed in Long COVID-19 patients.
  • The hypothesis of dysautonomia contributing to Long COVID-19 symptoms warrants further investigation.

Purpose of the Study:

  • To investigate the presence and extent of dysautonomia in Long COVID-19 patients.
  • To analyze heart rate variability (HRV) using 12-lead 24-h ECG monitoring in Long COVID-19 patients compared to a control group.
  • To identify correlations between HRV parameters, specific biomarkers, and Long COVID-19 status.

Main Methods:

  • Recruitment of 30 Long COVID-19 patients and 20 control subjects with no history of COVID-19.
  • Utilized 12-lead 24-h electrocardiogram (ECG) monitoring for comprehensive heart rate variability assessment.
  • Employed power spectral analysis to evaluate HRV components (Total Power, VLF, HF) and the LF/HF ratio.

Main Results:

  • Long COVID-19 patients demonstrated significantly lower total power (p < 0.0001) and HF component (p = 0.015) of HRV.
  • A significantly higher LF/HF ratio (p = 0.001) was observed in Long COVID-19 patients, indicating sympathetic-vagal imbalance.
  • Multivariable analysis revealed significant correlations between Long COVID-19 and D-dimer (β=0.259), NT-ProBNP (β=0.281), HF component (β=0.696), and LF/HF ratio (β=0.820).

Conclusions:

  • Dysautonomia, specifically impaired vagal activity, is a significant finding in Long COVID-19 patients.
  • Persistent procoagulative state (elevated D-dimer) and myocardial strain (elevated NT-ProBNP) may contribute to vagal impairment.
  • Careful monitoring and intervention are crucial for Long COVID-19 patients due to impaired vagal activity, elevated NT-ProBNP, and a prothrombotic state.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
24
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
57
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
572
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
53
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
36
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.1K